Pacira Biosciences, Inc. (PCRX)
24.90
+0.82
(+3.41%)
USD |
NASDAQ |
Sep 16, 16:00
24.90
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Price : 24.90 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 24.63 | 24.94 | 23.65 | 24.08 | 824514.0 |
| Sep 14, 2026 | 25.71 | 25.99 | 24.65 | 24.68 | 418438.0 |
| Sep 11, 2026 | 25.43 | 25.57 | 25.18 | 25.36 | 538041.0 |
| Sep 10, 2026 | 25.92 | 26.00 | 25.10 | 25.16 | 733774.0 |
| Sep 09, 2026 | 25.62 | 25.88 | 25.13 | 25.88 | 571737.0 |
| Sep 08, 2026 | 25.98 | 26.41 | 25.68 | 25.87 | 386424.0 |
| Sep 04, 2026 | 26.38 | 26.65 | 26.31 | 26.35 | 481690.0 |
| Sep 03, 2026 | 26.74 | 26.84 | 26.32 | 26.60 | 598521.0 |
| Sep 02, 2026 | 26.52 | 26.91 | 26.24 | 26.58 | 610789.0 |
| Sep 01, 2026 | 26.01 | 26.50 | 25.98 | 26.47 | 729463.0 |
| Aug 31, 2026 | 25.75 | 26.07 | 25.46 | 25.90 | 380508.0 |
| Aug 28, 2026 | 25.74 | 26.04 | 25.56 | 25.76 | 483553.0 |
| Aug 27, 2026 | 25.63 | 26.03 | 25.36 | 25.83 | 413397.0 |
| Aug 26, 2026 | 25.46 | 26.02 | 25.32 | 25.90 | 506086.0 |
| Aug 25, 2026 | 24.89 | 25.58 | 24.80 | 25.53 | 379713.0 |
| Aug 24, 2026 | 24.60 | 25.04 | 24.49 | 24.86 | 336672.0 |
| Aug 21, 2026 | 23.91 | 24.72 | 23.66 | 24.67 | 475873.0 |
| Aug 20, 2026 | 24.11 | 24.40 | 23.72 | 23.83 | 402799.0 |
| Aug 19, 2026 | 24.04 | 24.58 | 24.04 | 24.36 | 336180.0 |
| Aug 18, 2026 | 23.32 | 24.04 | 23.32 | 24.00 | 443569.0 |
| Aug 17, 2026 | 23.23 | 23.72 | 22.97 | 23.24 | 653871.0 |
| Aug 14, 2026 | 23.21 | 23.37 | 22.79 | 23.00 | 645095.0 |
| Aug 13, 2026 | 24.08 | 24.28 | 23.00 | 23.18 | 806769.0 |
| Aug 12, 2026 | 24.38 | 24.54 | 23.52 | 23.70 | 758838.0 |
| Aug 11, 2026 | 24.49 | 24.78 | 24.26 | 24.38 | 802591.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zimmer Biomet Holdings, Inc. | 96.84 |
| Liquidia Corp. | 68.46 |
| Johnson & Johnson | 267.38 |
| Merck & Co., Inc. | 144.95 |
| ANI Pharmaceuticals, Inc. | 73.62 |
Price Related Metrics
| PE Ratio | 71.74 |
| PS Ratio | 1.407 |
| Price to Book Value | 1.476 |
| Price to Free Cash Flow | 5.848 |
| Earnings Yield | 1.39% |
| Market Cap | 991.58M |
| Operating PE Ratio | 38.00 |
| Normalized PE Ratio | 51.11 |